Rare Endocrinology News

Spotlight On

Stiff person syndrome (SPS)

A rare, progressive syndrome that affects the nervous system, specifically the brain and spinal cord

Prevalence

1-9 / 1,000,000

331-2,979

US Estimated

513-4,622

Europe Estimated

Age of Onset

ICD-10

G25.8

Inheritance

This condition does not appear to have a clear pattern of inheritance.

5 Facts you should know

FACT

1

Symptoms may include extreme muscle stiffness, rigidity and painful spasms in the trunk and limbs, severely impairing mobility

 

FACT

2

Initially, stiffness occurs in the thoracolumbar paraspinal and abdominal muscles

 

FACT

3

People with SPS often have heightened sensitivity to noise, sudden movements, and emotional distress, which can set off muscle spasms

 

FACT

4

Spasms can generate enough force to fracture a bone

 

FACT

5

Persistent symptoms can lead to abnormal posturing of the spine

 

Stiff person syndrome is also known as...

Stiff person syndrome is also known as:

  • Stiff man syndrome
  • Morsch Woltman syndrome
  • SPS
     

What’s your Rare IQ?

Which female singing star was diagnosed with stiff person syndrome?

Common signs & symptoms

Anxiety

EMG abnormality

Falls

Hyperhidrosis

Intermittent painful muscle spasms

Agoraphobia

Autoimmune antibody positivity

Difficulty walking

Current treatments

Treatment aims to control symptoms and improve mobility and function. While some people on treatment for SPS may maintain reasonable levels of activity, the majority become increasingly disabled over time. Treatment options depend on the symptoms and severity in each person and may include:

Benzodiazepines these are drugs that slow down the nervous system and may relieve muscle spasms and anxiety. They are generally considered the best initial therapy for SPS. Examples include diazepam and clonazepam.

Baclofen this is a muscle relaxant that may be used for people in whom benzodiazepines are not effective or not well-tolerated. Some people benefit from using baclofen in addition to benzodiazepines.

Immune modulating therapies these may be considered in people with severe symptoms who do not experience relief with benzodiazepines and baclofen. Options may include intravenous immune globulin (IVIG) therapy, plasmapheresis (also called plasma exchange), and rituximab. However studies supporting the effectiveness and safety of these therapies for SPS are limited.

Physical therapy and occupational therapy are also an important part of management for SPS and may help with side effects of medications (such as weakness) in addition to symptoms of the disease.

Top Clinical Trials

Top Treatments in Research